Tempus Ai Cl A (TEM)

May 13, 2025, 4:05 PM EDT - 6 hours ago

Tempus Announces Six Posters Accepted for Presentation at ISPOR 2025

May 7, 2025, 4:24 PM EDT - 6 days ago

Tempus AI Rallies After Q1 Beat, Analyst Notes AI-Driven Platform And Expanding Pharma Deals

May 6, 2025, 8:18 PM EDT - 7 days ago

Tempus AI, Inc. (TEM) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:01 PM EDT - 7 days ago

Tempus Reports First Quarter 2025 Results

May 5, 2025, 8:30 AM EDT - 8 days ago

Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry

May 1, 2025, 8:30 AM EDT - 12 days ago

Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment

Apr 29, 2025, 8:30 AM EDT - 14 days ago

Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection

Apr 28, 2025, 8:30 AM EDT - 15 days ago

Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform

Apr 25, 2025, 8:30 AM EDT - 18 days ago

Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025

Apr 24, 2025, 8:30 AM EDT - 19 days ago

Tempus to Report First Quarter 2025 Financial Results on May 6

Apr 23, 2025, 8:00 AM EDT - 20 days ago

Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology

AZN

Apr 22, 2025, 6:34 AM EDT - 21 days ago

Tempus AI: Cooldown Arrived (Rating Upgrade)

Apr 18, 2025, 8:30 AM EDT - 25 days ago

Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S.

Apr 15, 2025, 9:15 AM EDT - 4 weeks ago

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation

ILMN

Apr 9, 2025, 3:01 AM EDT - 4 weeks ago

Is it safe to buy the Tempus AI stock dip now?

Mar 29, 2025, 8:30 AM EDT - 6 weeks ago

Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting

Mar 26, 2025, 8:30 AM EDT - 6 weeks ago

Tempus to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 18, 2025, 4:23 AM EDT - 2 months ago

Tempus AI: The Investment Opportunity Of A Decade, Strong Buy

Mar 11, 2025, 5:15 PM EDT - 2 months ago

Tempus Announces Acquisition of Deep 6 AI

Feb 26, 2025, 8:05 AM EST - 2 months ago

Tempus AI: Buying The Dip After 2025 Guidance Raise

Feb 25, 2025, 6:30 AM EST - 2 months ago

Tempus AI Earnings: A Promising Business, But There Are Risks

Feb 24, 2025, 9:38 PM EST - 2 months ago

Tempus AI, Inc. (TEM) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 4:01 PM EST - 2 months ago

Tempus Reports Fourth Quarter and Full Year 2024 Results

Feb 24, 2025, 11:09 AM EST - 2 months ago

Tempus AI Gears Up For Q4 Earnings After 101% YTD Surge

Feb 21, 2025, 4:21 PM EST - 2 months ago

3 Biotech/Healthcare Names Under $10 I Am Buying Now

ARDX GERN MRNA PSNL

Feb 19, 2025, 8:30 AM EST - 2 months ago

Tempus to Present at TD Cowen's 45th Annual Health Care Conference

Feb 18, 2025, 4:30 PM EST - 3 months ago

Ares Management Upsizes Tempus Debt Facilities to $560 Million

ARES

Feb 18, 2025, 9:00 AM EST - 3 months ago

Tempus AI Is A Buy On Dips In The AI-Driven Healthcare Sector

Feb 18, 2025, 8:30 AM EST - 3 months ago

Tempus to Participate in the Morgan Stanley Technology, Media and Telecom Conference

Feb 13, 2025, 8:30 AM EST - 3 months ago

Tempus Announces Collaboration with IFLI Aimed at Supporting Development of Targeted Therapies for Follicular Lymphoma

Feb 11, 2025, 8:30 AM EST - 3 months ago

Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24

Feb 5, 2025, 9:42 AM EST - 3 months ago

Tempus AI: In Vogue, But Better To Wait For Some Retracement

Feb 3, 2025, 11:12 PM EST - 3 months ago

Tempus AI stock price is not cheap: is it a good buy?

Feb 3, 2025, 4:30 PM EST - 3 months ago

Tempus Completes Acquisition of Ambry Genetics

Jan 28, 2025, 8:00 AM EST - 3 months ago

Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways

Jan 28, 2025, 6:31 AM EST - 3 months ago

Tempus AI: Bringing The Promise Of AI To Healthcare

Jan 27, 2025, 10:14 AM EST - 3 months ago

What's Happening With Tempus AI (TEM) Stock?

Jan 23, 2025, 3:08 PM EST - 3 months ago

Tempus AI: Wait For A Cooldown

Jan 23, 2025, 2:16 AM EST - 3 months ago

Tempus AI's Flywheel Effect: Monetizing Data In Precision Medicine

Jan 21, 2025, 6:35 PM EST - 4 months ago

Here's Why This Medical AI Stock Soared 35% on Tuesday

Jan 21, 2025, 3:14 PM EST - 4 months ago

Tempus AI Has A High Probability Of Profitability In 2025

Jan 21, 2025, 10:11 AM EST - 4 months ago

This Medical AI Stock Is Up 30% After Launch of Personal Health App

Jan 21, 2025, 8:30 AM EST - 4 months ago

Tempus Announces National Launch of olivia, its AI-enabled Personal Health Concierge App for Patients

Jan 15, 2025, 8:30 AM EST - 4 months ago

Tempus Announces the National Launch of FDA-Approved xT CDx Test

Jan 15, 2025, 4:53 AM EST - 4 months ago

Tempus AI: Disappointing Q4 Preliminary Results, But Bullish Fundamental Update

Jan 14, 2025, 8:30 AM EST - 4 months ago

Tempus One Introduces New GenAI Capabilities to Query Millions of Unstructured Documents for Research and Clinical Care

Jan 13, 2025, 8:30 AM EST - 4 months ago

Tempus Announces Its First-Ever, Whole-Genome Sequencing Assay, xH

Jan 13, 2025, 8:00 AM EST - 4 months ago

Tempus Announces Preliminary Fourth Quarter and Full Year 2024 Results

Jan 8, 2025, 8:30 AM EST - 4 months ago

Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms